ROYAL BANK OF CANADA - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$133,000
+343.3%
8,266
+551.4%
0.00%
Q2 2023$30,000
-85.6%
1,269
-85.8%
0.00%
Q1 2023$208,000
-23.8%
8,927
-52.4%
0.00%
Q4 2022$273,000
+520.5%
18,762
+702.1%
0.00%
Q3 2022$44,000
+33.3%
2,339
+29.0%
0.00%
Q2 2022$33,000
-77.7%
1,813
-69.0%
0.00%
Q1 2022$148,000
-64.1%
5,849
-60.9%
0.00%
Q4 2021$412,000
+17.0%
14,971
+37.7%
0.00%
Q3 2021$352,000
+65.3%
10,870
+55.5%
0.00%
Q2 2021$213,000
+82.1%
6,991
+81.4%
0.00%
Q1 2021$117,000
-77.9%
3,853
-85.6%
0.00%
Q4 2020$529,000
+61.3%
26,733
+6.3%
0.00%
Q3 2020$328,000
+29.6%
25,144
+12.5%
0.00%
Q2 2020$253,000
-86.5%
22,360
-82.9%
0.00%
Q1 2020$1,872,000
-67.6%
130,858
-38.3%
0.00%
-100.0%
Q4 2019$5,773,000
+5504.9%
212,004
+5772.7%
0.00%
Q3 2019$103,000
-72.0%
3,610
-72.7%
0.00%
Q2 2019$368,000
+148.6%
13,229
+196.5%
0.00%
Q1 2019$148,000
+32.1%
4,462
+15.9%
0.00%
Q4 2018$112,000
-98.6%
3,850
-97.8%
0.00%
-100.0%
Q3 2018$8,161,000
+1838.5%
177,421
+1471.5%
0.00%
Q2 2018$421,000
+209.6%
11,290
+145.6%
0.00%
Q1 2018$136,000
+37.4%
4,597
+59.5%
0.00%
Q4 2017$99,000
-70.4%
2,882
-68.8%
0.00%
Q3 2017$334,000
+167.2%
9,225
+89.8%
0.00%
Q2 2017$125,000
-46.8%
4,860
-60.2%
0.00%
Q1 2017$235,000
+32.8%
12,222
+14.9%
0.00%
Q4 2016$177,000
+67.0%
10,639
+107.9%
0.00%
Q3 2016$106,000
-67.0%
5,118
-50.9%
0.00%
Q2 2016$321,000
-0.3%
10,431
+21.6%
0.00%
Q1 2016$322,000
-72.9%
8,580
-68.8%
0.00%
-100.0%
Q4 2015$1,187,000
+109.3%
27,469
+81.4%
0.00%
Q3 2015$567,000
-28.8%
15,144
-35.4%
0.00%
-100.0%
Q2 2015$796,000
-17.3%
23,427
-13.9%
0.00%0.0%
Q1 2015$963,000
-20.1%
27,220
-23.1%
0.00%0.0%
Q4 2014$1,206,000
-48.8%
35,390
-42.0%
0.00%
-50.0%
Q3 2014$2,354,000
-34.7%
61,056
-34.1%
0.00%0.0%
Q2 2014$3,606,000
-50.2%
92,651
-56.3%
0.00%
-60.0%
Q1 2014$7,247,000
+45.5%
211,925
-10.7%
0.01%
+25.0%
Q4 2013$4,981,000
+324.3%
237,421
+375.3%
0.00%
+300.0%
Q3 2013$1,174,000
+10.7%
49,951
+26.4%
0.00%0.0%
Q2 2013$1,061,00039,5140.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders